Genomic Valley Biotech Ltd Share Price

Miscellaneous

BSE: 539206 Small Cap ISIN: INE574D01010

As on 18 July 2026 at 19:29 IST

Stock Not Traded in BSE

Over 1 Month

15.58%

Over 6 Months

5.81%

Over 1 Year

-41.91%

Over 3 Years

25.63%

Genomic Valley Biotech Ltd Summary

Close ₹27.30

Open ₹27.30

High ₹27.30

Low ₹27.30

Volume 28

Net Turnover (in Cr) ₹0.000076

52Wk High ₹54.27

52Wk Low ₹20.10

52Wk High / Low

20.10

54.27

Genomic Valley Biotech Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹8.34

EPS (TTM) 0.10

Book Value (BV) 12.85

Div. Yield -

P/E (TTM) 273

Price/Book Value 2.12

Delivery % -

Face Value 10

Key Ratios

PE Ratio 50.08

PB Ratio 4.59

EV to Sales 21.25

PEG Ratio 0.02

ROA 9.23

ROE 9.69

Debt-Equity -

Net Profit Margin 42.86

Operating Profit Margin 52.38

Genomic Valley Biotech Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	0.85	0.17	2.77	0.15	0.21
Total Expenses	0.41	0.15	1.85	0.58	0.71
Profit Before Tax	0.44	0.02	0.65	-0	-0.50
Profit After Tax	0.36	0.02	0.65	-0.01	-0.56
Operating Profit After Depreciation	0.44	0.02	0.91	-0.38	-0.32

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	0.01	0	0	1.75	5.86
Total Non Current Assets	1.73	1.42	1.84	2.66	7.45
Total Current Assets	2.62	2.91	2.58	1.14	0.16
Total Assets	4.36	4.33	4.42	3.80	7.62
Total Shareholder's Fund	3.90	3.54	3.53	2.88	4.49

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	0.03	-0.02	-0.78	-2.13	1.48
Net Cash Used In Investing Activities	0.01	-0.02	1.52	3.67	-1.58
Net Cash Used In Financing Activities	-	-	-0.70	-1.55	0.07

No data available

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	0.04	0.05	0.09	0.09	0.26
Total Expenses	0.04	0.04	0.09	0.07	0.26
Profit Before Tax	-	0.01	-	0.02	-
Profit After Tax	-0.01	0.01	-	0.02	-0.08
Operating Profit after Depreciation	-	0.01	-	0.02	-

Genomic Valley Biotech Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 27.30

S2 27.30

S3 27.30

Pivot 27.30

R1 27.30

R2 27.30

R3 27.30

Moving Average

20 SMA 25.74

50 SMA 26.48

100 SMA 26

200 SMA 29.82

Genomic Valley Biotech Ltd Corporate Actions

No available data

AGM Date: 31 Dec 2021

Genomic Valley Biotech Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from December 25, 2021 to December 31, 2021 (both days inclusive) for the purpose of 27th Annual General Meeting (AGM) of the Company to be held on December 31, 2021. Pursuant to Regulation 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 27th Annual General Meeting (27th AGM) of Genomic Valley Biotech Limited ('Company') is scheduled to be held on Friday, December 31, 2021 at 09.30 A.M. at the Registered Office of the Company at 4 K.M. Stone, Berri Chharra Road, P.O. Tandaheri, Teh. Bahadurgarh, Dist. Jhajjar, Haryana-124507. The Notice for the said Annual General Meeting and Annual Report 2020-21 is enclosed herewith. (As Per BSE Announcement dated 07.12.2021) We wish to inform you that the 27th Annual General Meeting (AGM) of the Company was held today at 09.30 A.M. at the Registered Office of the Company situated at 4 K.M. Stone, Berri Chharra Road, P.O. Tandaheri, Teh. Bahadurgarh, Dist. Jhajjar, Haryana-124507. In this regard, we hereby submit the proceedings of the 27th AGM of the Company as required under Regulation 30 read with Part A of Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 which is enclosed herewith. (As Per BSE Announcement Dated on 31.12.2021) Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby submitting the Voting Results alongwith the Scrutinizer Report issued by Scrutinizer appointed for conducting remote e-voting and voting at the venue of Annual General Meeting. (As Per BSE Announcement Dated on 01.01.2022) Pursuant to applicable Regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the signed copy of Minutes of Annual General Meeting of the Company held on 31st December, 2021. Pursuant to applicable Regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the signed copy of Minutes of Annual General Meeting of the Company held on 31st December, 2021. (As Per BSE Announcement Dated on 21.01.2022)

AGM Date: 30 Dec 2022

This is to inform you that pursuant to the provisions of Section 96(1) of the Companies Act, 2013, Genomic Valley Biotech Limited ('GVBL or the Company') has filed an application before Registrar of Companies, NCT of Delhi and Haryana (ROC) for an extension of holding Annual General Meeting (AGM) for the Financial Year 2021-22. The Registrar of Companies on receipt of application has approved the application on the reasons and circumstances stated therein and extended the date of Annual General Meeting (AGM) for three (3) Months. AGM Extension Approval granted by the Registrar of Companies is enclosed herewith. Please take the above on records. Outcomes of Board Meeting held on 26th November, 2022 Genomic Valley Biotech Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from 24th December, 2022 to 30th December, 2022 (both days inclusive) for the purpose of 28th Annual General Meeting (AGM) of the Company to be held on December 30, 2022. (As Per BSE Announcement Dated on 26.11.2022) Pursuant to the provisions of Section 91 of the Companies Act, 2013 and Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Register of Members and the Share Transfer Books of the Company will remain closed from Saturday 24th December, 2022 to Friday 30th December, 2022 (both days inclusive) for the purpose of 28th Annual General Meeting of the Company which will be held on Friday, December 30, 2022 at 09.30 A.M. at the Registered Office of the Company at 4 K.M. Stone, Berri Chharra Road, P.O. Tandaheri, Teh. Bahadurgarh, Dist. Jhajjar, Haryana-124507. (As per BSE Announcement Dated on 06/12/2022) Pursuant to Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 28th Annual General Meeting (28th AGM) of Genomic Valley Biotech Limited ('Company') is scheduled to be held on Friday, December 30, 2022 at 09.30 A.M. at the Registered Office of the Company at 4 K.M. Stone, Berri Chharra Road, P.O. Tandaheri, Teh. Bahadurgarh, Dist. Jhajjar, Haryana-124507. The Notice for the said Annual General Meeting and Annual Report 2021-22 is enclosed herewith. With reference to the above captioned subject and pursuant to Regulation 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 28th Annual General Meeting (28th AGM) of Genomic Valley Biotech Limited ('Company') is scheduled to be held on Friday, December 30, 2022 at 09.30 A.M. at the Registered Office of the Company at 4 K.M. Stone, Berri Chharra Road, P.O. Tandaheri, Teh. Bahadurgarh, Dist. Jhajjar, Haryana-124507. The Notice for the said Annual General Meeting and Annual Report 2021-22 is enclosed herewith. (As Per BSE Announcement Dated on 07/12/2022) Outcome of 28th Annual General Meeting (AGM) held on 30th December, 2022 Details of Voting Results alongwith Scrutinizer Report of the 28th Annual General Meeting (AGM) pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 (As Per BSE Announcement Dated on 30/12/2022) Signed Minutes of Annual General Meeting held on 30.12.2022 (As Per BSE Announcement Dated on 19/01/2023)

AGM Date: 30 Sep 2023

Notice of Book Closure for purpose of AGM Detail of Voting Results along with Scrutinizer Report of 29th Annual General Meeting held on 30.09.2023 (As Per BSE Announcement dated on 30.09.2023)

AGM Date: 30 Dec 2024

AGM 30/12/2024 Please Find enclosed herewith the Outcome of the Board Meeting dated 06/12/2024 for your reference. Please find enclosed herewith book closure intimation for your reference. (As Per BSE Announcement dated on 06.12.2024) Please Find enclosed herewith copy of proceeding of the 30th Annual General Meeting of the Company for your reference. (As per BSE Announcement Dated on 30/12/2024) Submission of Voting Results of 30th Annual General Meeting Of The Company Under Regulation 44(3) Of the SEBI Listing Obligations & disclosure Requirements ) Regulations ,2015 (As Per Bse Announcement Dated on 31.12.2024)

AGM Date: 31 Dec 2025

Please find enclosed herewith book closure intimation for your reference. Please find enclosed herewith copy of proceeding of 31st Annual General Meeting of the company for your reference. (As per BSE Announcement dated on: 31.12.2025) Submission of voting results of 31st Annual General Meeting of the Company under Regulation 44(3) of the SEBI (listing Obligations & Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated on 01.01.2026)

Genomic Valley Biotech Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
GMR Airports Ltd	₹100.10	₹1,05,695.35
Max Financial Services Ltd	₹1,561.55	₹53,891.40
NBCC (India) Ltd	₹100.55	₹27,148.50
Central Mine Planning & Design Institute Ltd	₹222.80	₹15,907.92
International Gemological Institute Limited	₹354	₹15,298.45

Genomic Valley Biotech Ltd Top Mutal Funds Invested

No data available

Genomic Valley Biotech Ltd News

Genomic Valley Biotech to announce Quarterly Result

On 29 May 2026

19 May 2026, 03:18 pm

Genomic Valley Biotech to conduct board meeting

On 15 January 2026

05 Jan 2026, 05:47 pm

Genomic Valley Biotech to hold AGM

On 31 December 2025

09 Dec 2025, 05:24 pm

Genomic Valley Biotech declare Quarterly Result

On 15 October 2025

08 Oct 2025, 12:31 pm

Genomic Valley Biotech to discuss results

On 7 August 2025

30 Jul 2025, 11:12 am

Genomic Valley Biotech Ltd Stock Analysis

Annual revenue for Genomic Valley Biotech Ltd increased by 409.32% to ₹0.85 crore in FY 2025 from ₹0.17 crore in FY 2024.
Annual Net Profit for Genomic Valley Biotech Ltd increased by 2245.53% to ₹0.36 crore in FY 2025 from ₹0.02 crore in FY 2024.
Promoter Shareholding in Genomic Valley Biotech Ltd remains unchanged by 0.00% in the most recent quarter, from 46.06% in December 2025 to 46.06% in March 2026.
Genomic Valley Biotech Ltd delivered a 1-year return of -41.91% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Genomic Valley Biotech Ltd share price moved down by 100.00% from its previous close of INR ₹27.30. The latest Genomic Valley Biotech Ltd share price is INR ₹0.
Genomic Valley Biotech Ltd share price today has been at a low of 27.30 and a high of 27.30. Over the past 52 weeks, the Genomic Valley Biotech Ltd share price has seen a low of 20.10 and a high of 54.27.